Document Detail

Atorvastatin attenuates NF-kappaB activation in trigeminal nucleus caudalis in a rat model of migraine.
MedLine Citation:
PMID:  19733216     Owner:  NLM     Status:  MEDLINE    
Nitroglycerin-induced NF-kappaB activation in trigeminal nucleus caudalis is believed to be partly involved in the pathogenesis of migraine. Atorvastatin, an inhibitor of HMG-CoA reductase, is thought to have pleiotropic effects in various neurologic diseases. Moreover, there are several lines of evidences that atorvastatin inhibits NF-kappaB activation in peripheral blood mononuclear cells. Thus, this study aims to explore whether atorvastatin attenuates NF-kappaB activation in trigeminal nucleus caudalis in a nitroglycerin-induced migraine model. A significant increase in nuclear content of p65, an indicator of NF-kappaB activation, was detected in trigeminal nucleus caudalis in rats following injection with nitroglycerin. However, the nitroglycerin-induced NF-kappaB activation in trigeminal nucleus caudalis was attenuated by pretreatment with atorvastatin in a dose-dependent fashion. These results suggest that atorvastatin may be a novel and promising candidate for future treatment or prophylaxis of migraine via attenuating activation of NF-kappaB in trigeminal nucleus caudalis.
Zhao Yin; Yannan Fang; Li Ren; Xiaojuan Wang; Aiwu Zhang; Jianwen Lin; Xianliang Li
Related Documents :
17611696 - Calyculin a induces apoptosis and stimulates phosphorylation of p65nf-kappab in human o...
18757306 - Carma3 mediates lysophosphatidic acid-stimulated cytokine secretion by bronchial epithe...
10416616 - The host environment promotes the constitutive activation of nuclear factor-kappab and ...
9427296 - Nuclear export signal of ikappabalpha interferes with the rev-dependent posttranscripti...
11032186 - Overexpression of s-adenosylmethionine decarboxylase (samdc) activates the maternal pro...
19573616 - Phenotypic analysis of genes whose mrna accumulation is dependent on calcineurin in asp...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-09-03
Journal Detail:
Title:  Neuroscience letters     Volume:  465     ISSN:  1872-7972     ISO Abbreviation:  Neurosci. Lett.     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-09-23     Completed Date:  2010-01-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7600130     Medline TA:  Neurosci Lett     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  61-5     Citation Subset:  IM    
Department of Neurology, The First Affiliated Hospital, Sun Yat-Sen University, No. 58 Zhongshan Road 2, Guangzhou 510080, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Analysis of Variance
Blotting, Western
Cell Nucleus / drug effects,  metabolism
Disease Models, Animal
Dose-Response Relationship, Drug
Fluorescent Antibody Technique
Heptanoic Acids / administration & dosage,  pharmacology*
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage,  pharmacology*
Migraine Disorders / chemically induced,  drug therapy*,  metabolism
NF-kappa B / metabolism*
Neoplasm Proteins / metabolism
Neurons / drug effects,  metabolism
Nucleocytoplasmic Transport Proteins / metabolism
Pyrroles / administration & dosage,  pharmacology*
Rats, Sprague-Dawley
Trigeminal Caudal Nucleus / drug effects*,  metabolism
Reg. No./Substance:
0/Heptanoic Acids; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/NF-kappa B; 0/Neoplasm Proteins; 0/Nucleocytoplasmic Transport Proteins; 0/Pyrroles; 0/p65 oncofetal mRNA transport protein, rat; 110862-48-1/atorvastatin; 55-63-0/Nitroglycerin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Perception based method for the investigation of audiovisual integration of speech.
Next Document:  Electrophysiological actions of the dopamine agonist apomorphine in the paraventricular nucleus duri...